Bang for the Buck: How Health Care Innovation Affects Life Expectancy and Patient Well-Being

November 11, 2020

During a webinar, experts discussed where health care has improved life expectancy and the relationship between cost and relative contribution that each area makes to life improvement and expectancy.

During a 60-minute discussion, the speakers on The American Journal of Managed Care® webinar "Bang for the Buck: How Health Care Innovation Affects Life Expectancy and Patient Well-Being" highlighted where health care has improved life expectancy and which areas (public health, drugs, hospital care, surgery, devices, etc.) have contributed the most.

The speakers framed the discussion around 3 papers published in the last year abut the connection between health care spending and value creation.

Robert W. Dubois, MD, PhD, interim president and CEO of the National Pharmaceutical Council, moderated the discussion with:

  • Mariam Alboustani, RPh, clinical pharmacy manager, Medicare Pharmacy Services, Blue Cross Blue Shield of Michigan
  • Jason Buxbaum, MHSA, PhD candidate, program in health policy, Harvard University
  • Michael Ciarametaro, MBA, vice president of research, National Pharmaceutical Council
  • David Cutler, PhD, Otto Eckstein Professor of Applied Economics, Harvard University

Let us know what you thought of the webinar and take our short survey.